Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma
1987532 citationsBerton Zbar, Hiltrud Brauch et al.Natureprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of M. Linehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Linehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Linehan more than expected).
This network shows the impact of papers produced by M. Linehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Linehan. The network helps show where M. Linehan may publish in the future.
Co-authorship network of co-authors of M. Linehan
This figure shows the co-authorship network connecting the top 25 collaborators of M. Linehan.
A scholar is included among the top collaborators of M. Linehan based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M. Linehan. M. Linehan is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
14 of 14 papers shown
1.
Toro, Jorge R., G.M. Glenn, Paul H. Duray, et al.. (1999). Birt-Hogg-Dubé Syndrome. Archives of Dermatology. 135(10). 1195–202.257 indexed citations
2.
Jin, Fuzi, et al.. (1997). The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers.. PubMed. 151(6). 1541–7.20 indexed citations
3.
Mulders, Peter F.A., Figlin Ra, Jean B. deKernion, et al.. (1997). Renal cell carcinoma: recent progress and future directions.. PubMed. 57(22). 5189–95.86 indexed citations
Reincke, Martín, Michael Karl, William D. Travis, et al.. (1994). P53 mutations in human adrenocortical neoplasms. The Journal of Clinical Endocrinology & Metabolism.3 indexed citations
6.
Nelkin, Barry D., Robert E. Reiter, James R. Gnarra, et al.. (1993). Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.. PubMed. 53(12). 2719–22.90 indexed citations
Zbar, Berton, et al.. (1987). Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature. 327(6124). 721–724.532 indexed citations breakdown →
14.
Belldegrun, Arie S., Suzanne L. Topalian, M. Linehan, C. Robertson, & Steven A. Rosenberg. (1987). Growth and antitumor activity of tumor-involved draining lymph node cells versus tumor-infiltrating lymphocytes from patients with renal cell cancer. 38. 688–690.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.